Ligand Pharmaceuticals Inc - Net Worth and Insider Trading
Ligand Pharmaceuticals Inc Net Worth
The estimated net worth of Ligand Pharmaceuticals Inc is at least $317 Million dollars as of 2024-11-29. Ligand Pharmaceuticals Inc is the 10% Owner of Viking Therapeutics Inc and owns about 5,819,383 shares of Viking Therapeutics Inc (VKTX) stock worth over $317 Million. Details can be seen in Ligand Pharmaceuticals Inc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ligand Pharmaceuticals Inc has not made any transactions after 2020-08-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ligand Pharmaceuticals Inc owns 4 companies in total, including Pfenex Inc (PFNX) , Viking Therapeutics Inc (VKTX) , and Ligand Pharmaceuticals Inc (LGND) among others .
Click here to see the complete history of Ligand Pharmaceuticals Inc’s form 4 insider trades.
Insider Ownership Summary of Ligand Pharmaceuticals Inc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PFNX | Pfenex Inc | 2020-10-01 | 10 percent owner |
VKTX | Viking Therapeutics Inc | 2020-08-26 | 10 percent owner |
LGND | Ligand Pharmaceuticals Inc | 2008-08-04 | director |
2022-09-30 | 10 percent owner |
Ligand Pharmaceuticals Inc Latest Holdings Summary
Ligand Pharmaceuticals Inc currently owns a total of 1 stock. Ligand Pharmaceuticals Inc owns 5,819,383 shares of Viking Therapeutics Inc (VKTX) as of August 26, 2020, with a value of $317 Million.
Latest Holdings of Ligand Pharmaceuticals Inc
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
VKTX | Viking Therapeutics Inc | 2020-08-26 | 5,819,383 | 54.51 | 317,214,567 |
Holding Weightings of Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Form 4 Trading Tracker
According to the SEC Form 4 filings, Ligand Pharmaceuticals Inc has made a total of 2 transactions in Viking Therapeutics Inc (VKTX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Viking Therapeutics Inc is the sale of 164,488 shares on August 26, 2020, which brought Ligand Pharmaceuticals Inc around $1 Million.
Insider Trading History of Ligand Pharmaceuticals Inc
- 1
Ligand Pharmaceuticals Inc Trading Performance
Ligand Pharmaceuticals Inc Ownership Network
Ligand Pharmaceuticals Inc Owned Company Details
What does Pfenex Inc do?
Who are the key executives at Pfenex Inc?
Ligand Pharmaceuticals Inc is the 10 percent owner of Pfenex Inc. Other key executives at Pfenex Inc include director & See Remarks Evert B. Schimmelpennink , Chief Operating Officer Shawn Scranton , and Chief Scientific Officer Martin Brenner .
Pfenex Inc (PFNX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pfenex Inc (PFNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pfenex Inc (PFNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pfenex Inc (PFNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pfenex Inc Insider Transactions
Ligand Pharmaceuticals Inc Mailing Address
Above is the net worth, insider trading, and ownership report for Ligand Pharmaceuticals Inc. You might contact Ligand Pharmaceuticals Inc via mailing address: 3911 Sorrento Valley Blvd, Suite 110, San Diego Ca 92121.